.Caporaso JG Kuczynski J Stombaugh J Bittinger K Bushman FD Costello EK Fierer N Gonzalez Pena AG Goodrich JK Gordon JI Huttley GA Kelley ST Kinghts D Koenig JE Ley RE Lozupone CA McDonald D Muegge BD Pirrung M Reeder J JRS Turnbaugh PJ Walters WA Widmann J Yatsunenko T Zaneveld J Knight R. 2010.

The fecal microbiota and metabolome were assessed immediately prior to antibiotic treatment baseline or time 1 T1 after 14 days of antibiotic treatment during the course of antibiotic treatment T2 and 9 days following the termination of antibiotics recovery T3.

.Fu J Bonder MJ Cenit MC Tigchelaar EF Maatman A Dekens JAM Brandsma E Marczynska J Imhann F Weersma RK Franke L Poon TWXavier RJ Gevers D Hofker MH Wijmenga C Zhernakova A.

.Ferrer M Ruiz A Lanza F Haange SB Oberbach A Till H Bargiela R Campoy C Segura MT Richter M von Bergen M Seifert J Suarez A.

The fecal microbial community of mice was analyzed immediately before treatment baseline T1 and after 14 days of antibiotic treatment T2 as well as at 9 days after antibiotic treatment T3 to analyze for recovery from antibiotics.

Vancomycin-imipenem also resulted in a significant difference in the fecal microbi- ota compositions t  10.43 Pperm  0.0003 5043 permutations and significantlyFIG 3 LEfSe comparison analysis between the control and ciprofloxacin or vancomycin-imipenem groups at the end of antibiotic treatment A or B respectively or 9 days after cessation of antibiotic treatment C or D respectively.

.Rogers GB Kozlowska J Keeble J Metcalfe K Fao M Dowd SE Mason AJ McGuckin MA Bruce KD.

.Yap IKS Li JV Saric J Martin FP Davies H Wang Y Wilson ID Nicholson JK Utzinger J Marchesi JR Holmes E. 2008.

.Ren W Chen S Yin J Duan J Li T Liu G Feng Z Tan B Yin Y Wu G. 2014.

.Xiao F Huang Z Li H Yu J Wang C Chen S Meng Q Cheng Y Gao X Li J Liu Y Guo F. 2011.

